Chemotherapy alone versus definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: a population-based study

Chemotherapy alone versus definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: a population-based study

Abstract Background The role of radiotherapy for cT4bNanyM0 esophageal squamous cell carcinoma (ESqCC) is relatively unclear, with both chemotherapy (C/T) alone and definitive concurrent chemoradiotherapy (dCCRT) being treatment options in the current guidelines. We aimed to compare the survival of...

Full description

Bibliographic Details
Main Authors:	Chia-Chin Li, Chih-Yi Chen, Ying-Hsiang Chou, Chih-Jen Huang, Hsiu-Ying Ku, Chun-Ru Chien
Format:	Article
Language:	English
Published:	BMC 2021-04-01
Series:	BMC Gastroenterology
Subjects:	Chemotherapy Definitive concurrent chemoradiotherapy Esophageal squamous cell carcinoma
Online Access:	https://doi.org/10.1186/s12876-021-01742-4

Similar Items

Optimal radiotherapy dose in cervical esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy: A population based study
by: Chia‐Chin Li, et al.
Published: (2021-07-01)

Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
by: Chih-Yi Chen, et al.
Published: (2018-07-01)

Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
by: Mingqiu Chen, et al.
Published: (2018-08-01)

Effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy
by: Yao‐Hung Kuo, et al.
Published: (2020-01-01)

The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy
by: Yen-Hao Chen, et al.
Published: (2018-08-01)

Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis
by: Jianing Wang, et al.
Published: (2021-09-01)

The treatment outcome of definitive chemoradiotherapy in patients with esophageal squamous cell carcinoma
by: Mahdi Seilanian Toosi, et al.
Published: (2007-10-01)

STAT3β Enhances Sensitivity to Concurrent Chemoradiotherapy by Inducing Cellular Necroptosis in Esophageal Squamous Cell Carcinoma
by: Zhen-Yuan Zheng, et al.
Published: (2021-02-01)

Primary tumor regression patterns in esophageal squamous cell cancer treated with definitive chemoradiotherapy and implications for surveillance schemes
by: Chen M, et al.
Published: (2019-04-01)

Proposed revision of the 8th edition AJCC clinical staging system for esophageal squamous cell cancer treated with definitive chemo-IMRT based on CT imaging
by: Mingqiu Chen, et al.
Published: (2019-03-01)

The Clinical Outcomes of Locally Advanced Cervical Esophageal Squamous Cell Carcinoma Patients Receiving Curative Concurrent Chemoradiotherapy: A Population-Based Propensity Score-Matched Analysis
by: Yen-Hao Chen, et al.
Published: (2019-03-01)

Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy
by: Yen-Hao Chen, et al.
Published: (2020-01-01)

Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A)
by: Mingqiu Chen, et al.
Published: (2020-01-01)

Predicting Severe Radiation Esophagitis in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: Construction and Validation of a Model Based in the Clinical and Dosimetric Parameters as Well as Inflammatory Indexes
by: Yilin Yu, et al.
Published: (2021-06-01)

A predictive model for treatment response in patients with locally advanced esophageal squamous cell carcinoma after concurrent chemoradiotherapy: based on SUVmean and NLR
by: Chunsheng Wang, et al.
Published: (2020-06-01)

Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score‐matched analysis
by: Chen Li, et al.
Published: (2021-06-01)

Inflammation-based prognostic scores predict the prognosis of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a propensity score-matched analysis
by: Chia-Che Wu, et al.
Published: (2018-09-01)

A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol
by: Chen Li, et al.
Published: (2019-04-01)

Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy
by: Ke Hu, et al.
Published: (2018-12-01)

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study
by: Jiahua Lyu, et al.
Published: (2018-11-01)

Neoadjuvant Chemoradiotherapy and Larynx-Preserving Surgery for Cervical Esophageal Cancer
by: Kun-Yao Dai, et al.
Published: (2020-02-01)

Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study
by: Takeshi Kawakami, et al.
Published: (2018-05-01)

Impact of the interval between neoadjuvant concurrent chemoradiotherapy and esophagectomy in the modern era: a population-based propensity-score-matched retrospective cohort study in Asia
by: Yao-Hung Kuo, et al.
Published: (2019-12-01)

The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma
by: Ming-Wei Ma, et al.
Published: (2018-08-01)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
by: Xi-Lei Zhou, et al.
Published: (2021-05-01)

The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy
by: Liu X, et al.
Published: (2017-02-01)

Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell Carcinoma
by: Wei-Cheng Lin, et al.
Published: (2019-10-01)

Endoscopic Submucosal Dissection Followed by Concurrent Chemoradiotherapy in Patients with Early Esophageal Cancer with a High Risk of Lymph Node Metastasis
by: Hee Kyung Kim, et al.
Published: (2019-09-01)

Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy
by: Ying-Ying Xu, et al.
Published: (2021-07-01)

Progress in Multimodal Treatment for Advanced Esophageal Squamous Cell Carcinoma: Results of Multi-Institutional Trials Conducted in Japan
by: Kazuo Koyanagi, et al.
Published: (2021-12-01)

A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol
by: Lin-rui Gao, et al.
Published: (2020-09-01)

A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence
by: Qi Liu, et al.
Published: (2020-04-01)

Combination of 35-Gene Mutation Profile and Radiotherapy Dosimetry Predicts the Therapeutic Outcome of Definitive Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma
by: Peng Tang, et al.
Published: (2021-08-01)

A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
by: Yun Chen, et al.
Published: (2018-02-01)

Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma
by: Toshiki Ikawa, et al.
Published: (2019-08-01)

The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
by: Chien-Ming Lo, et al.
Published: (2021-03-01)

Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma
by: Chang, W.-L, et al.
Published: (2022)

Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma
by: Chang, W.-L, et al.
Published: (2022)

The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma
by: Song T, et al.
Published: (2020-03-01)

High Mean Corpuscular Volume as a Predictor of Poor Overall Survival in Patients with Esophageal Cancer Receiving Concurrent Chemoradiotherapy
by: Li K, et al.
Published: (2020-08-01)